The Valley Desk

ArticleRheumatology and therapyPublished

Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Hospital of the University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Rheumatology and therapy
Published
Subject terms
Rheumatoid arthritis; Effectiveness; Infliximab; Biosimilar; Biologic; Dmard; Tnfα Inhibition; Real-world Evidence; Ifx-dyyb; Corevitas Registry
PubMed ID
38507187
PubMed Central ID
PMC11111629
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal